PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Disclosure D-Day Draws Near in Europe

FDA's Breakthrough Designation is Working

Raising the Stakes on Value-Based Pricing

Top Story
Pharma Under Fire for Driving Opioid Abuse “Epidemic”
The public outcry for action to address opioid-related addiction and deaths has intensified demands for change in the prescribing, dispensing, labeling, and marketing of prescription pain medications. Jill Wechsler reports
... /Read more/
Advertisement
6 STEPS TO ENSURE SUCCESSFUL PATIENT ACCESS TO INNOVATIVE THERAPIES
LIVE WEBCAST: Thursday, May 26, 2016 at 4 pm BST | 5 pm CEST
Free registration
Pharma Futures
Facebook’s New Algorithm: Attention, Engagement and World Domination
Facebook is the number one social-media network for businesses. Peter Houston asks, How can pharma stay relevant in the feed?
... /Read more/
Advertisement
Understanding the Chronic Disease Patient Journey in Emerging Markets
LIVE WEBCAST: Thursday, May 12, 2016, 11 am EDT / 4 pm BST /
5 pm CEST
Register now and join market research consultants Marc Yates and Rachel Howard for this complimentary webinar in which they will explore the chronic disease patient journey in emerging markets. Utilising local knowledge and detailed case studies, they will examine the patient journey from origination through to presentation, diagnosis, treatment choice, follow up and compliance and outline both the opportunities and challenges for global pharma at each stage.
Free registration
Pharma Futures
Alphabet’s (fka Google) Health Care Laundry List
When an 800-pound gorilla stakes a claim in an industry sector, the incumbents sit up and take notice—particularly when the gorilla is named Alphabet and is the parent company of Google. Cassie Arnold reports.
... /Read more/
Advertisement
Medical science liaisons Optimizing their impact during product launch
Live webinar: Tuesday, May 3, 2016 at 11:00 am EDT • 4:00 pm BST • 5:00 pm CEST
Register now>>
Europe
Drug Pricing: The Subject That Won’t Go Away
Which medicines should Europe's health systems pay for – and how much should they pay? Drug pricing is the subject that just won't go away, writes Reflector.
... /Read more/
SPONSORED
Global Innovators Gather in Philadelphia for DIA 2016
DIA 2016 is DIA's global annual meeting to advance health care product development around the world by connecting stakeholders to interdisciplinary insights and innovation
... /Read more/
Emerging Pharma Leaders
Pharm Exec’s Emerging Pharma Leaders 2016 — Final Chance to Nominate
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input. Tell us who you think should be included as one of our 2016 Emerging Pharma Leaders. These leaders are vital to the future of the industry, and you can help ensure they get the recognition they deserve. Fill out your nomination today
... /Read more/
ADVERTISEMENT
Calendar
/ May 12: FT Healthcare & Life Sciences Summit /
New York, NY
/ June 6–9: BIO International Convention /
San Francisco, CA.
/ June 21–22: Patient Engagement Solutions Summit /
Princeton, NJ
/ June 22–23: Global Medical Information and Communications Summit /
Barcelona, Spain.
/ August 15–17: 10th Annual Forum on Transparency and Aggregate Spend /
Washington, DC.
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
Industry update
//Astellas (Northbrook, IL) appointed Mark Wanda to its Ethics and Compliance organization as Executive Director, Anti-Bribery and Anti-Corruption. Succeeding Wanda in his previous role as Deputy General Counsel will be Nahrin Marino, who will continue to serve as Director of Investigations. The company also promoted Matt Silversten to Deputy General Counsel. Silversten will be the new head of the Astellas US Legal department's litigation and risk management team.//Vernalis Therapeutics (Berwyn, PA) announced the appointment of Sandford (Sandy) Sommer as President & Chief Operating Officer, effective May 2.//Intouch Solutions (New York, NY) announced the launch of Intouch Market Access and hired Peter Weissberg as Group Director of Market Access.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com